Gender aspects of pharmacokinetics of new and old AEDs: Pregnancy and breast-feeding

Therapeutic Drug Monitoring

Volumn 27, Issue 6, 2005, Pages 718-721

  Tomson, Torbjörn ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antiepileptic drugs; Breast milk; Epilepsy; Pharmacokinetics; Pregnancy

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETHOSUXIMIDE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

BREAST FEEDING; CONFERENCE PAPER; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG EXCRETION; DRUG PROTEIN BINDING; EPILEPSY; HUMAN; LACTATION; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SEX DIFFERENCE; UMBILICAL CORD; UNSPECIFIED SIDE EFFECT; ARTICLE; FEMALE; INFANT; METABOLIC CLEARANCE RATE; PHYSIOLOGY;

ANTICONVULSANTS; BREAST FEEDING; FEMALE; HUMANS; INFANT; LACTATION; METABOLIC CLEARANCE RATE; PREGNANCY; SEX FACTORS;

EID: 33646837183     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ftd.0000179843.63515.8f     Document Type: Conference Paper

References (32)

1. Tomson T, Battino D, Perucca E. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy. Epilepsia. 2004;45:1171-1175.
2. Hägg S, Spigset O. Anticonvulsant use during lactation. Drug Saf. 2000;22:425-440.
3. Perucca E. Drug metabolism in pregnancy, infancy and childhood. Pharmacol Ther. 1987;34:129-143.
4. Pennell PB. Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology. 2003;61(Suppl 2):S35-S42.
5. Yerby MS,Friel PN. McCormick K. Antiepileptic drug disposition during pregnancy. Neurology. 1992;42(Suppl 5):12-16.
6. Battino D, Binelli S, Bossi L, et al. Changes in primidone/phenobarbital ratio during pregnancy and the puerperium. Clin Pharmacokinet. 1984;9:252-260.
7. Tomson T, Lindbom U, Ekqvist B, et al. Epilepsy and pregnancy: a prospective study of seizure control in relation to free and total plasma concentrations of carbamazepine and phenytoin. Epilepsia. 1994;35:122-130.
8. Tomson T, Öhman I, Vitols S. Lamotrigine in pregnancy and lactation: a case report. Epilepsia. 1997;38:1039-1041.
9. Öhman I, Vitols S, Tomson T. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia. 2000;41:709-713.
10. Tran TA, Leppik IE, Blesi K, et al. Lamotrigine clearance during pregnancy. Neurology. 2002;59:251-255.
11. Pennell PB, Newport DJ, Stowe ZN, et al. The impact of pregnancy and childbirth on the metabolism of lamotrigine. Neurology. 2004;62:292-295.
12. de Haan GJ, Edelbroek P, Segers J, et al. Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study. Neurology. 2004;63:571-573.
13. Pennell PB, Ritchie JC, Newport DJ, et al. Defining fetal exposure to lamotrigine (abstract). Epilepsia. 2004;45(Suppl. 7):233.
14. Garnett WR. Lamotrigine: pharmacokinetics. J Child Neurol. 1997;12 (Suppl 1):S10-S15.
15. May TW, Korn-Merker E, Rambeck B. Clinical pharmacokinetics of oxcarbazepine. Clin Pharmacokinet. 2003;42:1023-1042.
16. Nau H, Kuhnz W, Egger HJ, et al. Anticonvulsants during pregnancy and lactation. Transplacental, maternal and neonatal pharmacokinetics. Clin Pharmacokinet. 1982;7:508-543.
17. Yerby MS, Friel PN, McCormick K, et al. Pharmacokinetics of anticonvulsants in pregnancy: alterations in plasma protein binding. Epilepsy Res. 1990;5:223-228.
18. Pienimaki P, Hartikainen AL, Arvela P, et al. Carbamazepine and its metabolites in human perfused placenta and in maternal and cord blood. Epilepsia. 1995;36:241-248.
19. Myllynen PK, Pienimäki PK, Vähänkangas KH. Transplacental passage of lamotrigine in a human placenta perfusion system in vitro and in maternal cord blood in vivo. Eur J Clin Pharmacol. 2003;58:677-682.
20. Bulau P, Paar WD, von Unruh GE. Pharmacokinetics of oxcarbazepine and 10-hydroxy-carbazepine in the newborn child of an oxcarbazepine-treated mother. Eur J Clin Pharmacol. 1988;34:311-313.
21. Myllynen P, Pienimäki P, Jouppila P, et al. Transplacental passage of oxcarbazepine and its metabolites in vivo. Epilepsia. 2001;42:1482-1485.
22. Öhman I, Vitols S, Luef G, et al. Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations. Epilepsia. 2002;43:1157-1160.
23. Kawada K, Itoh S, Kusaka T, et al. Pharmacokinetics of zonisamide in perinatal period. Brain Dev. 2002;24:95-97.
24. Johannessen SI, Helde G, Brodtkorb E. Levetiracetam concentrations in serum and in breast-milk at birth and during lactation. Epilepsia. 2005;46:1-3.
25. Öhman I, Vitols S, Tomson T. Pharmacokinetics of gabapentin in neonates and during lactation. Abstract. World Congress on Clinical Pharmacology & Therapeutics (CPT 2004), Brisbane, 2004.
26. Stewart BH, Kugler AR, Thompson PR, et al. A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of lack of proportionality between increasing dose and drug levels in plasma. Pharm Res. 1993;10:276-281.
27. Nau H, Kuhnz W, Egger HJ, et al. Anticonvulsants during pregnancy and lactation. Transplacental, maternal and neonatal pharmacokinetics. Clin Pharmacokinet. 1982;7:508-543.
28. Von Unruh GE, Froescher W, Hoffmann F, et al. Valproic acid in breastmilk: how much is really there? Ther Drug Monit. 1984;6:272-276.
29. Froescher W, Eichelbaum M, Niesen M, et al. Carbamazepine levels in breast-milk. Ther Drug Monit. 1984;6:266-271.
30. Kuhnz W, Koch S, Jakob S, et al. Ethosuxumide in epileptic women during pregnancy and lactation period. Placental transfer, serum concentrations in nursed infants and clinical status. Br J Clin Pharmacol. 1984;18:671-677.
31. Kuhnz W, Koch S, Helge H, et al. Primidone and phenobarbital during lactation period in epileptic women: total and free drug serum levels in the nursed infants and their effects on neonatal behaviour. Dev Pharmacol Ther. 1988;11:147-154.
32. Shimoyama R, Ohkubo T, Sugawara K. Monitoring of zonisamide in human breast milk and maternal plasma by solid-phase extraction HPLC method. Biomed Chromatogr. 1999;13:370-372.